In another study, the authors present a clear evidence for an association between TLR4 polymorphisms and CRC, suggesting that these polymorphisms could possibly serve as biomarkers for decision making in CRC treatment [38]. The gene discussed is TLR4; the disease is colorectal carcinoma.